Dominik Naczynski - Profile and Investment Details

Investor Profile

Dominik Naczynski is a Venture Capital, Investor, Private Equity Firm based in San Diego County, California, United States with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences, Encoded Therapeutics, Nabriva Therapeutics, Cullinan Oncology, Silverback Therapeutics, Telesta Therapeutics, Prevail Therapeutics, Nuvation Bio, Scorpion Therapeutics, PMV Pharmaceuticals, Cabaletta Bio, Attune Pharmaceuticals, Pandion Therapeutics, CiVi Biopharma, GTx, Vividion Therapeutics, Akero Therapeutics, Codiak Biosciences, Elevation Oncology, Atreca, Asher Bio, Sojournix, Cedilla Therapeutics, G1 Therapeutics, Shoreline Biosciences, Solid Biosciences, Milestone Pharmaceuticals, Passage Bio, Centessa Pharmaceuticals, Biomea Fusion, BioAtla, Poseida Therapeutics, MEI Pharma, Achilles Therapeutics, Kinnate Biopharma, Day One Biopharmaceuticals, Revolution Medicines, Boundless Bio, Rain Therapeutics, IDEAYA Biosciences, Mereo Biopharma, ITeos Therapeutics, Nurix Therapeutics, Syndax Pharmaceuticals, Tango Therapeutics, Connect Biopharmaceuticals, Vivace Therapeutics. Over time, Dominik Naczynski has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Dominik Naczynski is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Women Led, Life Science, Information Technology (IT), Biotech, Healthcare, Biotechnology, Consumer Health, Health and Hospital Services, Health IT, Digital Health, Travel, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Dominik Naczynski, as their portfolio suggests a familiarity and interest in this area.

Understanding Dominik Naczynski’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.